Put Options

13 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 15, 2024

SELL
$26.4 - $32.56 $488,400 - $602,360
-18,500 Reduced 38.14%
30,000 $812,000
Q4 2023

Feb 14, 2024

BUY
$23.37 - $28.68 $432,345 - $530,580
18,500 Added 61.67%
48,500 $1.35 Million
Q3 2023

Nov 14, 2023

BUY
$27.17 - $31.97 $815,100 - $959,100
30,000 New
30,000 $840,000
Q3 2022

Nov 14, 2022

BUY
$22.0 - $31.87 $110,000 - $159,350
5,000 Added 20.0%
30,000 $669,000
Q2 2022

Aug 15, 2022

SELL
$26.4 - $30.54 $3.56 Million - $4.12 Million
-135,000 Reduced 84.38%
25,000 $745,000
Q1 2022

May 13, 2022

SELL
$23.07 - $27.99 $6.86 Million - $8.32 Million
-297,400 Reduced 65.02%
160,000 $4.21 Million
Q4 2021

Feb 11, 2022

SELL
$21.47 - $32.08 $1.73 Million - $2.59 Million
-80,700 Reduced 15.0%
457,400 $10.6 Million
Q3 2021

Nov 12, 2021

SELL
$23.37 - $32.13 $308,484 - $424,116
-13,200 Reduced 2.39%
538,100 $16.6 Million
Q2 2021

Aug 16, 2021

SELL
$18.78 - $25.15 $7.67 Million - $10.3 Million
-408,500 Reduced 42.56%
551,300 $13.5 Million
Q1 2021

May 17, 2021

BUY
$18.21 - $23.2 $9 Million - $11.5 Million
494,500 Added 106.28%
959,800 $17.9 Million
Q4 2020

Feb 16, 2021

SELL
$15.39 - $22.1 $2.12 Million - $3.05 Million
-138,000 Reduced 22.87%
465,300 $9.28 Million
Q3 2020

Nov 16, 2020

BUY
$16.16 - $20.66 $2.23 Million - $2.86 Million
138,300 Added 29.74%
603,300 $10 Million
Q2 2020

Aug 14, 2020

BUY
$13.31 - $19.41 $6.19 Million - $9.03 Million
465,000 New
465,000 $9.02 Million

Others Institutions Holding ALKS

About Alkermes plc.


  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $4.94B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Caption Management, LLC Portfolio

Follow Caption Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.